secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolus, Inc. (EOLS)
CIK:        0001570562
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0001570562-25-000069
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolus refinances with $250M credit facility, cuts interest cost by 350 bps
---------------------------------------------------------------------------

- New $250M senior secured term loan replaces existing $125M facility; $150M drawn at closing, $100M incremental capacity available in two $50M tranches through Dec 31, 2026.
- Interest rate reduced by 350 bps to SOFR + 5.00% (floor 3.50%); quarterly interest payments, bullet maturity at 5 years.
- Converted from amortizing to bullet maturity; significantly reduced prepayment fees; no additional performance conditions or financial covenants for incremental tranches.
- Evolus no longer required to make principal payments in 2026; refinancing enhances cash generation and financial flexibility.
- Funds managed by Pharmakon Advisors, LP; Leerink Partners served as exclusive financial advisor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1570562/000157056225000069/0001570562-25-000069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1570562/000157056225000069/eols-20250505.htm
  HTML page:      https://secwatch.observer/filing/0001570562-25-000069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer